You can run a UK telehealth service from outside the UK — but the regulated activities (dispensing, prescribing) must be performed by UK-registered entities and clinicians, and the company structure typically needs UK substance. The commercial direction and brand operation can sit anywhere; the regulated layers must sit in the UK. This piece walks through what can and cannot be done remotely.
The regulated layer must be UK-based
UK telehealth dispensing requires a GPhC-registered pharmacy operating from UK premises with a UK-resident superintendent pharmacist. UK telehealth prescribing requires UK-registered clinicians (GMC, GPhC, NMC, or equivalent) practising under UK clinical governance. These cannot be moved offshore.
An overseas founder can launch a UK telehealth brand — but the dispensing pharmacy and prescriber network must be UK-resident and UK-regulated. The white-label partnership model is well-suited to this; the founder operates from anywhere while the UK partner operates the regulated layers.
Company structure for overseas founders
Most UK telehealth services operate via a UK-incorporated company. The reasons: CQC registration typically requires UK provider entity, professional indemnity insurance is usually structured around UK entities, banking and payment processing is simpler with UK incorporation, and tax substance is cleaner.
Overseas founders typically incorporate a UK limited company as the operating vehicle, with appropriate share structure and director appointments. UK director residency is not strictly required but is often practically helpful for banking and operational continuity.
Banking, payments, and operational practicalities
UK telehealth services need UK-based payment processing (Stripe UK, Adyen UK, etc.) to process patient payments in GBP. UK banking is needed for operational accounts. UK payroll if employing UK staff. These all require UK company substance.
Founder time-zone is typically not the binding constraint — operational hours can be staffed by UK-based team members. The binding constraint is the regulatory and commercial substance, not the founder's location.
CQC registration and clinical governance from overseas
CQC registration in England requires a UK provider entity and a UK-resident registered manager (typically a senior clinician). The registered manager must be substantively involved in the operation. An overseas founder cannot serve as the registered manager unless they relocate or have a credible part-time UK presence.
Most overseas founders address this by appointing a UK-resident senior clinician as registered manager and as a director of the UK company. This works well when the senior clinician is genuinely engaged with the operation.
Marketing to UK patients from overseas
Marketing UK telehealth services to UK patients is subject to UK rules — ASA, CAP Code, MHRA medicines advertising restrictions — regardless of where the marketing operation is based. An overseas marketing team must work within UK rules.
The same applies to data handling. UK patient data is subject to UK GDPR and DPA 2018. Overseas processing requires appropriate safeguards (international data transfer mechanisms) and documented compliance.
How PExpo enables overseas founders to operate UK telehealth
PExpo's brand model is well-suited to overseas founders launching a UK telehealth brand. The UK regulated layers — dispensing, prescribers, clinical governance, pharmacovigilance — are operated by PExpo's UK pharmacy operation. The brand operates patient-facing with UK rules but can be founded and run from anywhere.
See our brand model page for what is included operationally, and our pricing page for the commercial structure including per-dispense terms.
The regulated layers — dispensing, prescribing, clinical governance — must be UK-resident and UK-regulated. The commercial direction and brand operation can sit anywhere. Founder location is rarely the binding constraint.
An overseas founder can launch a UK telehealth brand. The dispensing pharmacy and prescriber network cannot follow them — those must stay UK-resident.
You can run a UK telehealth service from outside the UK, but the regulated activities must sit with UK-registered entities and clinicians, and the company structure typically requires UK substance. The white-label partnership model is well-suited to overseas founders — UK regulated layers operated by the partner, brand direction and commercial operation operated from anywhere. See our brand model page and pricing page for the commercial structure.
Frequently asked questions
Can I be a UK telehealth company director if I live abroad?
Yes — UK company law does not strictly require UK-resident directors. However, banking, operational continuity, and some regulatory expectations are easier with at least one UK-resident director. Many overseas-founded UK telehealth companies have a UK-resident director alongside overseas founders.
Does PExpo work with US-based or EU-based founders launching UK telehealth brands?
Yes — PExpo's white-label brand model is structured to support overseas founders. The UK regulated layers (dispensing, prescribing) sit with PExpo's UK pharmacy operation; the brand operates from anywhere within UK rules. See our brand model page.
Can a UK telehealth brand serve patients in the EU or US too?
Cross-border telehealth across UK, EU, and US requires separate regulatory alignment in each jurisdiction — UK rules do not extend automatically. Most operators launch in one jurisdiction first and expand cautiously.
